Device
Angio-Seal
Angio-Seal is a medical device with 3 clinical trials. Historical success rate of 50.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
2
67%
Ph phase_4
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
33.3%
1 of 3 finished
Non-Completion Rate
66.7%
2 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(2)
Detailed Status
Withdrawn1
Completed1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (33.3%)
N/A2 (66.7%)
Trials by Status
withdrawn133%
completed133%
terminated133%
Recent Activity
0 active trials
Showing 3 of 3
completednot_applicable
Femoral Closure Versus Radial Compression Devices Related to Percutaneous Coronary Interventions Study
NCT02455661
terminatednot_applicable
AGIR Study: Angio-Seal in Interventional Radiology
NCT01911403
withdrawnphase_4
Star-Close Versus Angio-Seal for Femoral Artery Hemostasis
NCT00590356
Clinical Trials (3)
Showing 3 of 3 trials
NCT02455661Not Applicable
Femoral Closure Versus Radial Compression Devices Related to Percutaneous Coronary Interventions Study
NCT01911403Not Applicable
AGIR Study: Angio-Seal in Interventional Radiology
NCT00590356Phase 4
Star-Close Versus Angio-Seal for Femoral Artery Hemostasis
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3